Lack of consideration of sex and gender in clinical trials for COVID-19
Preprint
Abstract
Sex and gender differences impact the incidence of SARS-CoV-2 infection and COVID-19 mortality. Furthermore, sex differences characterize the frequency and severity of pharmacological side effects. A large number of clinical trials are ongoing to develop new therapeutic approaches and vaccines for COVID-19. We investigated the inclusion of sex and/or gender in currently registered studies on http://ClinicalTrials.gov . Only 416 (16.7%) of the 2,484 registered SARS-CoV-2/COVID-19 trials mention sex/gender as recruitment criterion and only 103 (4.1%) allude to sex/gender in the description of the analysis phase. None of the 11 clinical trials published in scientific journals on June 2020 reported sex-disaggregated results. Hence, lack of consideration upon registration does not seem to be corrected during trial execution and reporting. Given the biological relevance and the potential risks of unwanted side effects, we urge researchers to focus on sex-disaggregated analyses already at the planning stage of COVID-19 trials.Keywords
All Related Versions
- Published version: Nature Communications, 12 (1), 1.
This publication has 16 references indexed in Scilit:
- Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysisMaturitas, 2020
- Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach UsAnnals of Internal Medicine, 2020
- Presence of Genetic Variants Among Young Men With Severe COVID-19JAMA, 2020
- Considering how biological sex impacts immune responses and COVID-19 outcomesNature Reviews Immunology, 2020
- Towards Precision Medicine: Inclusion of Sex and Gender Aspects in COVID-19 Clinical Studies—Acting Now before It Is Too Late—A Joint Call for ActionInternational Journal of Environmental Research and Public Health, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- COVID-19: the gendered impacts of the outbreakThe Lancet, 2020
- Why sex and gender matter in implementation researchBMC Medical Research Methodology, 2016
- Sex differences in immune responsesNature Reviews Immunology, 2016
- The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory PolicyJournal of Women's Health, 2007